Abstract
dc:description.abstractPancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterised by extreme stromal desmoplasia, immune evasion, and resistance to therapy. Focal Adhesion Kinase (FAK) is a central transducer that integrates signals from the extracellular matrix and growth factors, yet its context-specific role in PDAC heterogeneity remains poorly defined. This thesis employed CRISPR-Cas9 engineered FAK knockout and matched wild-type models across fourteen genetically diverse PDAC lines, combined with Data-Independent Acquisition (DIA) proteomics, to map the signalling landscape governed by FAK. Comparative proteomic and pathway analyses revealed that FAK loss alters networks controlling adhesion dynamics, interferon signalling, and antigen processing. Notably, FAK suppression increased expression of immunoproteasome subunits PSMB8/9/10, enhancing pathways linked to MHC class I presentation and suggesting a mechanistic link between FAK activity and immune invisibility. Cross-species validation using murine interactomics confirmed conservation of these immune-modulatory effects. Integrating these data across the hallmarks of cancer highlights FAK as a key regulator of PDAC plasticity and immune escape. The work establishes a proteomic framework for evaluating FAK-targeting strategies and supports combining FAK inhibition with immunotherapeutic approaches to re-sensitise PDAC to immune surveillance.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Slawinska, Aleksandra Dominika
- Advisors dc:contributor.advisor
-
- Serrels, Alan
- Byron, Adam
- Von Kriegsheim, Alex
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7330